A new technique for implantation of tissue culture melanoma cells in a murine model of metastatic ocular melanoma

Melanoma Research

Volumn 10, Issue 1, 2000, Pages 2-8

  Dithmar, S ^a   Rusciano, D ^c   Grossniklaus, H E ^a,b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY EYE CENTER   (United States)

^c FRIEDRICH MIESCHER INSTITUTE FOR BIOMEDICAL RESEARCH   (Switzerland)

Author keywords

Intraocular melanoma; Liver metastasis; Murine model

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHOROID MELANOMA; CILIARY BODY; COMPARTMENT SYNDROME; CONTROLLED STUDY; ENUCLEATION; IMPLANTATION; INOCULATION; LIVER METASTASIS; MELANOMA CELL; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; TECHNIQUE; TISSUE CULTURE; TUMOR GROWTH;

EID: 0034053102     PISSN: 09608931     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008390-200002000-00001     Document Type: Article

References (15)

1. 1. Strickland D, Lee JAH. Melanomas of eye: stability of rates. Am J Epidemiol 1981; 113: 700-702.
2. 2. Diener-West M, Hawkins BS, Markowitz JA, Schachat AP. A review of mortality from choroidal melanoma II. A meta-analysis of 5-year mortality rates following enucleation, 1966 through 1988. Arch Ophthalmol 1992; 110: 245-250.
3. 3. Seddon JM, Albert DM, Lavin PT, Robinson N. A prognostic factor study of disease-free interval and survival following enucleation for uveal melanoma. Arch Ophthalmol 1983; 101: 1894-1895.
4. 4. Grossniklaus HE, Barron BC, Wilson MW. Murine model of anterior and posterior ocular melanoma. Curr Eye Res 1995; 14: 399-404.
5. 5. Grossniklaus HE, Wilson MW, Barron BC, Lynn MJ. Anterior vs posterior intraocular melanoma. Metastatic differences in a murine model. Arch Ophthalmol 1996; 114: 1116-1120.
6. 6. Grossniklaus HE. Tumor vascularity and hematogenous metastasis in experimental murine intraocular melanoma. Trans Am Ophthalmol Soc 1998; 136: 721-752.
7. 7. Rusciano D, Lorezoni P, Burger MM. Murine model of liver metastasis. Inv Metastasis 1994-95; 14: 349-361.
8. 8. Kath R, Hayungs J, Bornfeld N, et al. Prognosis and treatment of disseminated uveal melanoma. Cancer 1993; 72: 2219-2223.
9. 9. Atzpodien J, Hänninen E, Kirchner H. Chemoimmunotherapy of advanced malignant melanoma: sequential administration of subcutaneous interleukin-2 and interferon-alpha after intravenous dacarbazine and carboplatin or intravenous darcabazine, cisplatin, carmustine and tamoxifen. Eur J Cancer 1995; 31A: 876-881.
10. m-labelled monoclonal antibodies. Nucl Med Commun 1996; 17: 346-352.
11. 11. Pyrhönen S. The treatment of metastatic uveal melanoma. Eur J Cancer 1998; 34: 27-30.
12. 12. Albert DM, Shadduck JA, Liu HA, et al. Animal models for the study of uveal melanoma. Int Ophthalmol Clin 1980; 10: 143-160.
13. 13. Kramer TR, Powell MB, Wilson MM, Salvatore J, Grossniklaus HE. Pigmented uveal tumours in a transgenic mouse model. Br J Ophthalmol 1998; 82: 953-960.
14. 14. Diaz CE, Rusciano D, Dithmar S, Grossniklaus HE. B16LS9 melanoma cells spread to the liver from the mutine ocular posterior compartment (PC). Curr Eye Res 1999; 18: 125-129.
15. 15. Dithmar S, Rusciano D, Armstrong CA, et al. Depletion of NK cell activity results in growth of hepatic micrometastases in a mutine ocular melanoma model. Curr Eye Res, in press.